Erdal Can Alkoclar

Principal Investigator(s):  View help for Principal Investigator(s) Erdal Can Alkoclar, Mas Pharmaceuticals Investment Corp

Version:  View help for Version V1

Name File Type Size Last Modified
15-antiviral-eng.docx application/vnd.openxmlformats-officedocument.wordprocessingml.document 22.2 KB 05/27/2019 10:03:PM

Project Citation: 

Alkoclar, Erdal Can . Erdal Can Alkoclar. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2019-05-28. https://doi.org/10.3886/E109942V1

Project Description

Summary:  View help for Summary An Antiviral Formulation consisting of 3 1-Protopanaxatriol
Analouges with Simultenaous DNA Polymerase and Ribonucleotide Reductase
Suppressive Properties
Funding Sources:  View help for Funding Sources Mas Pharmaceuticals (1.000.000.00 USD)



Related Publications

Download this project

Published Versions

V1 [2019-05-28]

Export Metadata

Dublin Core

DDI 2.5

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.